Event Videos
https://pubmed.ncbi.nlm.nih.gov/34310440/ J Pediatr Gastroenterol Nutr. 2021 Jul 23. Safety, Feasibility, Yield, Diagnostic and Prognostic Implications of Transjugular Liver Biopsy in Children and Adolescents Bikrant Bihari Lal 1, Vikrant Sood, Archana Rastogi, Amar Mukund, Rajeev Khanna, Manoj Kumar Sharma, Seema Alam Abstract Published on:
Jul-2021
|
https://pubmed.ncbi.nlm.nih.gov/34328446/ The Changing Epidemiology of Liver Disease Among US Children and Adolescents From 1999 to 2016 Jie Li 1, Michael H Le 2, Monique T Barakat 2 3, Ramsey C Cheung 2 4, Mindie H Nguyen 2 5 Abstract Introduction: Nonalcoholic fatty liver disease (NAFLD) and infection with hepatitis B virus (HBV) or hepatitis C virus (HCV) are major causes of liver disease in adults. However, data for children and adolescents are limited. Our study aimed to characterize the prevalence, trend, and risk factors of infection of HBV and HCV and possible NAFLD for this population. Published on:
Jul-2021
|
https://pubmed.ncbi.nlm.nih.gov/34316471/ Biliary atresia Pediatr Gastroenterol Hepatol Nutr. 2021 Jul;24(4):366-376. Analysis of Cholangitis Rates with Extended Perioperative Antibiotics and Adjuvant Corticosteroids in Biliary Atresia Lynette Goh 1, Kong Boo Phua 1, Yee Low 2, Li Wei Chiang 2, Chen Yong 2, Fang Kuan Chiou 1 Abstract Purpose: There is no consensus regarding adjuvant therapies following Kasai portoenterostomy (KP) for biliary atresia (BA). This study aimed to analyze the effect of extended perioperative intravenous antibiotics (PI-Abx) and adjuvant corticosteroid on cholangitis and jaundice clearance rates in the 3 years post-KP in children with BA. Published on:
Jul-2021
|
https://pubmed.ncbi.nlm.nih.gov/34104147/ chronic liver disease Pak J Med Sci. May-Jun 2021;37(3):680-683. Clinical spectrum of chronic liver disease with final outcome in children at a tertiary centre: A single - centre study Iqtadar Seerat 1, Eitzaz Ud Din Khan 2, Muhammad Atique 3, Usman Iqbal Aujla 4 Abstract Published on:
Jun-2021
|
https://pubmed.ncbi.nlm.nih.gov/34320247/liver transplantation Addressing social adversity to improve outcomes for children after liver transplant Sharad I Wadhwani 1, Laura Gottlieb 1, John C Bucuvalas 2 3, Courtney Lyles 1, Jennifer C Lai 1 Abstract Published on:
Jul-2021
|
https://pubmed.ncbi.nlm.nih.gov/34107368/ Liver transplant Transplant Rev (Orlando). 2021 May 29;35(4):100630. Portal vein obstruction after pediatric liver transplantation: A systematic review of current treatment strategies Bader A Alfares 1, Reinoud P H Bokkers 2, Henkjan J Verkade 3, Rudi A J O Dierckx 2, Girish Gupte 4, Stéphanie Franchi-Abella 5, Ruben H de Kleine 6, Hubert P J van der Doef 7 Abstract Published on:
Jun-2021
|
https://pubmed.ncbi.nlm.nih.gov/34321421/ NAFLD J Pediatr Gastroenterol Nutr. 2021 Jul 27. Unhealthy Eating, Psychopathology, and Nonalcoholic Fatty Liver Disease in Youth Presenting for Bariatric Surgery Sanita L Ley 1, Meg H Zeller, Jennifer Reiter-Purtill, David E Kleiner, John Dixon, Stavra Xanthakos, Teen View Study Group and in collaboration with the Teen-LABS Consortium Abstract Published on:
Jul-2021
|
https://pubmed.ncbi.nlm.nih.gov/34135158/ Cholestatsis Indian J Pathol Microbiol. 2021 Jun;64(Supplement):S146-S148. Benign recurrent intrahepatic cholestasis - 2 (BRIC-2)/ABCB11 deficiency in a young child - Report from a tertiary care center in South India K V Kalaranjini 1, Jinu A Glaxon 1, Sheela Vasudevan 1, M L Arunkumar 2 Published on:
Jun-2021
|
ttps://pubmed.ncbi.nlm.nih.gov/34321846/ NAFLD Review World J Gastroenterol. 2021 Jul 7;27(25):3815-3824. Advances in paediatric nonalcoholic fatty liver disease: Role of lipidomics Abstract Published on:
Jul-2021
|
https://pubmed.ncbi.nlm.nih.gov/34141782/ World J Clin Cases. 2021 Jun 16;9(17):4199-4209. COVID-19 in gastroenterology and hepatology: Lessons learned and questions to be answered Shao Liu 1, Mi-Mi Tang 1, Jie Du 1, Zhi-Cheng Gong 1, Shu-Sen Sun 2 Background: Although coronavirus disease 2019 (COVID-19) presents primarily as a lower respiratory tract infection, increasing data suggests multiorgan, including the gastrointestinal (GI) tract and liver, involvement in patients who are infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Aim: To provide a comprehensive overview of COVID-19 in gastroenterology and hepatology. Published on:
Jun-2021
|